During the past decade, Bernhoven conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 6 clinical trials were completed, i.e. on average, 16.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bernhoven" #1 sponsor was "Radboud University Medical Center" with 12 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bernhoven" #1 collaborator was "Bernhoven Hospital" with 6 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 6 trials as a collaborator, "Leiden University Medical Center" with 4 trials as a collaborator, "Erasmus Medical Center" with 3 trials as a collaborator and "Radboud University Medical Center" with 3 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "Bernhoven" are "Heart Failure" (3 trials), "Ulcerative Colitis" (3 trials), "Breast Neoplasms" (2 trials), "Cardiovascular Disease" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Bernhoven" in a lesser frequency.

Most popular intervention types in "Bernhoven" are "Drug" (24 trials), "Other" (10 trials), "Behavioral" (5 trials), "Procedure" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Mirikizumab" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Add-on Therapy for Axial Spondyloarthritis" (1 trials) and "Adherence Improving self-Management Strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bernhoven" are 36 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bernhoven". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Bernhoven, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Bernhoven, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".